期刊
MEDICINA CLINICA
卷 155, 期 11, 页码 494-501出版社
ELSEVIER ESPANA SLU
DOI: 10.1016/j.medcli.2020.05.009
关键词
Systemic lupus erythematosus; Update; Classification criteria; Biomarkers; New treatments
Systemic lupus erythematosus (SLE) is a complex autoimmune multisystemic disease of great clinical heterogeneity and significant potential morbidity and mortality. Although the outlook for patients with SLE has greatly improved, many unmet needs remain. In this review we aim to summarize the most relevant data on SLE that have emerged in recent years. In particular we discuss the new classification criteria from the European League Against Rheumatism and American College of Rheumatology, new biomarkers, novel definitions of remission and low lupus disease activity and what has emerged on new drugs and new therapeutic strategies. (c) 2020 Elsevier Espana, S.L.U. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据